Incidence of cystic fibrosis in the Albanian population

Pediatric Pulmonology

Volumn 43, Issue 11, 2008, Pages 1124-1129

  Festini, Filippo ^a   Taccetti, Giovanni ^b   Repetto, Teresa ^b   Mannini, Claudia ^a   Neri, Stella ^a   Bisogni, Sofia ^a   De Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Cystic Fibrosis Center of Tuscany   (Italy)

Author keywords

Albania; Cystic fibrosis; Hypertripsinaemia; Incidence

Indexed keywords

CHLORIDE; LACTASE;

ALBANIA; ARTICLE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; DIAGNOSTIC KIT; ETHNIC GROUP; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; SWEAT TEST;

ALBANIA; CYSTIC FIBROSIS; EMIGRANTS AND IMMIGRANTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFANT, NEWBORN; ITALY; MALE; MASS SCREENING; POPULATION SURVEILLANCE; PREVALENCE;

EID: 57349101917     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20920     Document Type: Article

References (32)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
2. Lewis PA. The epidemiology of cystic fibrosis. In: Hodson ME, Geddes DM, editors. Cystic fibrosis. London: Chapman & Hall Medical; 1995. pp. 1-4.
3. Phillips OP, Bishop C, Woods D, Elias S. Cystic fibrosis mutations among African Americans in the southeastern United States. J Natl Med Assoc 1995;87:433-435.
4. Kunitomo K, Komi N, Kawahito M, Miura M, Sasaki K. Cystic fibrosi in Japan. Tokushima J Exp Med 1991;38:85-89.
5. Bossi A, Casazza G, Padoan R, Milani S. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Hum Biol 2004;76:455-467.
6. Farrell MD, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001;107:1-13.
7. Dankert-Roelse JE, Mérelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 2005;147:15-20.
8. Mastella G, Zanolla L, Castellani C, Altieri S, Furnari M, Giglio L, Lombardo M, Miano A, Sciuto C, Pardo F, Magazzù G. Neonatal screening for cystic fibrosis: long term clinical balance. Pancreatology 2001;1:531-537.
9. Ranieri E, Lewis BD, Gerace RL, Ryall RG, Morris CP, Nelson PV, Carey WF, Robertson EF. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years experience. Br Med J 1994;308:1969.
10. Festini F, Taccetti G, Zilja R, Mergni G. Cystic fibrosis newborn screening in a heterogeneous population. Pediatr Pulmonol 2004; 38(Suppl. 27):324.
11. Pederzini F, Faraguna D, Giglio L, Pedrotti D, Perobelli L, Mastella G. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both? Acta Pediatr Scand 1990;79:935-942.
12. Castellani C, Bonizzato A, Cabrini G, Mastella G. Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity. Acta Paediatr 1997;86:497-502.
13. Taccetti G, Festini F, Mergni G, Centrone C, Marianelli L, de Martino M. Neonatal screening for cystic fibrosis: the Tuscan experience. Pediatr Pulmonol 2003;36(Suppl 25):221-222.
14. Marianelli L, Taccetti G, Farina S, Cioni ML, Mergni GF, Festini F, Torricelli F, Pelo E, Minuti B, Centrone C. Screening in Tuscany Newborn for Cystic fibrosis using immunoreactive trypsinogen test, molecular analysis on blood spot sample and measurement of lactase activity on meconium. Telethon Foundation, Italy; Grant n. EC1208. Proceedings of XI Telethon Scientific Convention; 2002 Nov 24-26; Riva del Garda, Italy: 360.
15. Tuscan Regional Government, Official Census data. 2006; www.regione.toscana.it.
16. Ofmann JJ, Badamgarav E, Henning JM, Knight K, Gano AD Jr, Levan RK, Gur-Arie S, Richards MS, Hasselblad V, Weingarten SR. Does disease management improve clinical and economic outcomes in patients with chronic disease? A systematic review. Am J Med 2004;117:182-192.
17. Festini F, Taccetti G, Cioni ML, Repetto T, de Martino M. High incidence of cystic fibrosis in children born in Italy to albanian immigrants. Thorax 2003;58:93.
18. Scotet V, De Braekeleer M, Audrézet MP, Lodé L, Verlingue C, Quéré I. Prevalence of CFTR mutations in hypertrypsinemia detected through neonatal screening for cystic fibrosis. Clin Genet 2001;59:42-47.
19. Festini F, Taccetti G, Repetto T, Reali MF, Campana S, Mergni GF, Marianelli L, de Martino M. Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study. J Pediatr 2005;197:316-320.
20. Scotet V, de Braekeleer M, Roussey M, Rault G, Parent P, Dagome M, Journel H, Lemoigne A, Codet JP, Catheline M, David V, Chaventré A, Duguépéroux I, Verlingue C, Quéré I, Mercier B, Audrézet MP, Férec C. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis. Lancet 2000;356:789-794.
21. Gibson LE, Cook RE. A test for concentration of electrolitytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis. Pediatrics 1959;23:545-549.
22. Taccetti G, Festini F, Braccini G, Campana S, de Martino M. Sweat testing in newborns positive to neonatal screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 2004;89:F463-F464.
23. Kule D, Mançellari A, Papapanagos H, Qirici S, Sanfey P. The causes and consequences of Albanian emigration during transition: evidence from microdata. Stud Econ 2000;4:1-24.
24. Albanian Human Development Report, United Nation Development Program. 2000; Available at http://www.al.undp.org, pp. 6-70.
25. Scotet V, Gillet D, Duguépéroux I, Audrézet MP, Bellis G, Gamier B, Roussey M, Rault G, Parent P, De Braekeleer M, Férec C. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. Hum Genet 2002;111:247-254.
26. Schwartz M, Sørensen N, Brandt NJ, Høgdall E, Holm T. High incidence of cystic fibrosis on the Faroe Islands: a molecular and genealogical study. Hum Genet 1995;95:703-706.
27. Daigneault J, Aubin G, Simard F, De Braekeleer M. Incidence of cystic fibrosis in Saguenay-Lac-St.-Jean (Quebec, Canada). Hum Biol 1992;64:115-119.
28. Allan JL, Phelan PD. Incidence of cystic fibrosis in ethnic Italians and Greeks and in Australians of predominantly British origin. Acta Paediatr Scand 1985;74:286-289.
29. Novelli G, Sangiuolo F, Mokini V, Cikuli M, Piazza A. Dalla piccola B. The cystic fibrosis delta F508 mutation in the Albanian population. Am J Hum Genet 1992;50:875-876.
30. Petreska L, Koceva S, Plaseska D, Chernick M, Gordova-Muratovska A, Fustic S, Nestorov R, Efremov GD. Molecular basis of cystic fibrosis in the Republic of Macedonia. Clin Genet 1998;54:203-209.
31. Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet 2003;63: 400-409.
32. Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M, Savic J, Minic P, Antoniadi T, Tzetis M, Kanavakis E. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis. Genet Test 2004;8:276-280.